BioSpace News Archive

Deals

DowDuPont Reports First Quarter 2019 Results

Net sales of $19.6 billion were down 9 percent compared with the year-ago period on lower local price of 4 percent, a 3 percent currency headwind and volume declines of 2 percent.

May 2, 2019
·
32 min read
Genetown

Insulet Celebrates New Global Headquarters and U.S. Manufacturing Facility in Acton, MA

Over $200 Million Investment in Massachusetts Creates Hundreds of Local Manufacturing Jobs and a Launchpad for New Product Innovation

May 2, 2019
·
4 min read
Deals

Novocure Reports First Quarter 2019 Financial Results and Provides Company Update

Quarterly net revenues of $73.3 million, representing 41 percent growth versus the first quarter 2018 and 5 percent growth versus the fourth quarter 2018

May 2, 2019
·
9 min read
Deals

Acorda Provides Update for First Quarter Ended March 31, 2019

INBRIJA™ (levodopa inhalation powder) commercially available on February 28; first and only FDA-approved inhaled levodopa for intermittent treatment of OFF episodes in people with Parkinson’s taking carbidopa/levodopa

May 2, 2019
·
13 min read
Deals

First Quarter 2019 Results for Materials Science Division¹ of DowDuPont

Net sales decreased 10 percent to $10.8 billion, in-line with the division’s modeling guidance. This compares to net sales of $12.0 billion in the year-ago period.

May 2, 2019
·
15 min read
Business

AmerisourceBergen Reports Fiscal 2019 Second Quarter Results

Revenues of $43.3 billion for the Second Quarter, a 5.6 Percent Increase Year-Over-Year

May 2, 2019
·
43 min read
Deals

Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress

Milestones anticipated throughout 2019 in clinical studies across all three franchises: depression, neurology and neuropsychiatry

May 2, 2019
·
19 min read
Business

Magellan Health Reports First Quarter 2019 Financial Results

Magellan Health, Inc. announced financial results for the first quarter ended March 31, 2019, as summarized below:

May 2, 2019
·
9 min read
Deals

Apax Funds, CPPIB and PSP Investments Agree to Sell Acelity and its KCI Subsidiaries to 3M for $6.725 Billion

KCI is a Leading Global Medical Technology Company Focused on Advanced Wound Care and Specialty Surgical Applications

May 2, 2019
·
6 min read
Lilly to Present New Data at AAN 2019 on Emgality® (galcanezumab-gnlm) and Lasmiditan Reinforcing Breadth of Headache Disorders Portfolio

19 abstracts to be presented, including Phase 3, eight-week data on Emgality for the preventive treatment of episodic cluster headache in adults, featured in a plenary presentation

May 2, 2019
·
13 min read